Compare MTD & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTD | ALC |
|---|---|---|
| Founded | 1991 | 1945 |
| Country | Switzerland | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6B | 32.4B |
| IPO Year | 1997 | 2002 |
| Metric | MTD | ALC |
|---|---|---|
| Price | $1,429.46 | $71.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $1,444.17 | $89.38 |
| AVG Volume (30 Days) | 162.9K | ★ 2.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.25% |
| EPS Growth | ★ 3.88 | N/A |
| EPS | ★ 19.87 | N/A |
| Revenue | ★ $4,026,399,000.00 | N/A |
| Revenue This Year | $6.07 | $7.99 |
| Revenue Next Year | $4.75 | $6.38 |
| P/E Ratio | $71.53 | ★ $38.31 |
| Revenue Growth | ★ 3.98 | N/A |
| 52 Week Low | $1,023.05 | $61.84 |
| 52 Week High | $1,525.17 | $90.41 |
| Indicator | MTD | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 67.44 | 53.52 |
| Support Level | $1,365.95 | $66.08 |
| Resistance Level | $1,503.55 | $69.75 |
| Average True Range (ATR) | 41.46 | 1.22 |
| MACD | 5.19 | 0.14 |
| Stochastic Oscillator | 79.42 | 67.27 |
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.